Wessman’s Aztiq Pharma Fund Signs $475m Partnership For Lotus And Adalvo
Consortium With Thai State-Owned Innobic Will Acquire Alvogen Emerging Market Holdings
Aztiq and Innobic aim to create a “powerful pharmaceuticals enterprise with global resources, networks and reach” after signing a definitive agreement to become the leading shareholders in Lotus Pharmaceutical and the sole shareholder in B2B firm Adalvo.
